Medical Countermeasures Against Chemical Threats

Skin, Eyes, and Mucous Membranes

Short-Term Goals

• Evaluate medical countermeasures used by Department of Defense (DoD) for the treatment of vesicating injuries for their use in civilian populations during mass casualty situations
• Evaluate and monitor promising ophthalmic drugs developed by DoD and assess their applicability for civilian populations and first responders
• Identify FDA-approved skin protectants against chemical agents for potential use in civilian populations
• Identify and validate appropriate in vitro systems and animal models for preclinical drug testing to develop treatments for injuries from caustic agents and vesicants